E-screen Assay 및 상경적 결합반응을 이용한 Phthalate Esters의 내분비계 장애 작용 연구

Study on Estrogenic Activities of Phthalate Esters Using E-screen Assay and Competitive Binding Assay

  • 한순영 (식품의약품안전청 국립독성연구소) ;
  • 한상국 (식품의약품안전청 국립독성연구소) ;
  • 문현주 (식품의약품안전청 국립독성연구소) ;
  • 김형식 (식품의약품안전청 국립독성연구소) ;
  • 이동하 (식품의약품안전청 국립독성연구소) ;
  • 김소희 (식품의약품안전청 국립독성연구소) ;
  • 김태성 (식품의약품안전청 국립독성연구소) ;
  • 박귀례 (식품의약품안전청 국립독성연구소)
  • 발행 : 2000.06.01

초록

Phthalate esters are used extensively as a plasticizer in the manufacture of plastic products such as PVC bags and medical devices. Recently, phthalate esters have been shown to induce endocrine system mediated responses. However. only a Jew studies have been conducted for estrogenic activity of phthalate esters. In this study estrogenic activities of seven phthalate esters. butyl benzyl phthalate (BBP), di(2-ethylhexyl) phthalate (DEHP), di-n-butylphthalate (DBP), diethylphthalate (DEP), di-n-pentylphthalate (DPP), di-n-propylphthalate (DPrP) and dicyclohexylphthalate (DCHP), were examined in vitro using E-screen assay and competitive binding assay. From the E-screen assay, BBP. DEHP. DBP and DEP showed weak estrogenic activity at the concentration of 5 $\mu\textrm{M}$. The relative proliferative effect (RPE) and the relative proliferative potency (RPP) were 50~70% and 0.01%. respectively, when compared with 500 pM of 17$\beta$-estradiol (E2). In competitive binding assay with the rat uterine estrogen receptor (ER), BBP and DEP showed weak binding potency [(l/$10^4$~1/$10^5$ of E2] while DEHP and DBP scarcely bound to ER. These results suggest that some phthalate esters have weak estrogenic activities in vitro.

키워드